NOT PEER-REVIEWED
"PeerJ Preprints" is a venue for early communication or feedback before peer review. Data may be preliminary.

A peer-reviewed article of this Preprint also exists.

View peer-reviewed version

Supplemental Information

Protocol for the London study

DOI: 10.7287/peerj.preprints.214v1/supp-1

Additional Information

Competing Interests

None of the authors have, or are likely to have, any competing interests arising from submission and publication of this manuscript.

Judith Kaufman is an employee of Royalheath Charitable Trust Limited. Other authors are, or were (Christine Brown is now retired), employees of the Medical Entomology Centre and received only salary emoluments whilst involved in performing this work.

Author Contributions

Ian F Burgess conceived and designed the experiments, performed the experiments, analyzed the data, wrote the paper, prepared figures and/or tables, reviewed drafts of the paper.

Christine M Brown conceived and designed the experiments, performed the experiments, reviewed drafts of the paper.

Nazma A Burgess conceived and designed the experiments, performed the experiments, reviewed drafts of the paper, community liaison Bangladesh, translation services.

Judith Kaufman conceived and designed the experiments, performed the experiments, reviewed drafts of the paper, community liaison London, pharmacy services.

Human Ethics

The following information was supplied relating to ethical approvals (i.e., approving body and any reference numbers):

Ethical approval in Dhaka was granted by the ad hoc ethics committee of the Metropolitan Medical Centre, Mohakhali, Dhaka; Protocol RAP001.

Ethics approval in North London was granted by Barnet Research Ethics Committee; Protocol RAP002.

Patent Disclosures

The following patent dependencies were disclosed by the authors:

Irwin RN. 1992. Benzodioxolane pesticides and pest repellents. UK Patent, GB 2 270 843.

Irwin RN. 1993. Louse repellent compositions. International Patent, WO 9502960 A1.

Oliver WJ. 1992. Louse repellent composition. UK Patent, GB 2 267 643 A.

Funding

The initial laboratory investigations and field studies were supported financially by Charwell Pharmaceuticals Ltd, Alton, UK, as part of a new product development programme prior to their acquisition by Pfizer Inc., and inclusion in Unicliffe Limited. Employees of Charwell Pharmaceuticals Ltd filed patents based on the work in support of a commercial product launch, but that intellectual property has now lapsed. The company did contribute ideas towards the design of the studies and conducted their own analyses of the results, which were not disclosed to the investigators. David Merrington contracted the work and William (Bill) Oliver and Richard Irwin provided technical and logistical support and study supplies. Monitoring of documentation from both field studies was performed by an appointee of Pfizer Inc. on behalf of Charwell Pharmaceuticals Ltd. Only as far as is stated in the Funding Statement


Add your feedback

Before adding feedback, consider if it can be asked as a question instead, and if so then use the Question tab. Pointing out typos is fine, but authors are encouraged to accept only substantially helpful feedback.

Some Markdown syntax is allowed: _italic_ **bold** ^superscript^ ~subscript~ %%blockquote%% [link text](link URL)
 
By posting this you agree to PeerJ's commenting policies
  Visitors   Views   Downloads